Ivy Brain Tumor Center Announces Promising Data for Niraparib in Phase 0/2 Glioblastoma Clinical Trial
November 17, 2023 08:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute announces promising results from a Phase 0/2 trial of niraparib in patients with newly...
Global Antibody Collaboration and Licensing Agreement Analysis Report 2023 with Directory of 1,812 Deals Signed Since 2016
November 17, 2023 06:43 ET
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Antibody Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
Proteomics Market Is Expected to Generate USD 98.1 Billion by 2031: Claims Allied Market Research
November 17, 2023 06:10 ET
|
Allied Analytics LLP
Wilmington, Delaware, Nov. 17, 2023 (GLOBE NEWSWIRE) -- As per the recent report published by Allied Market Research, the global proteomics market size is expected to gain $98.1 billion by 2031. The...
Genome Editing Market revenue to hit USD 69.6 Billion by 2036, says Research Nester
November 14, 2023 05:30 ET
|
Research Nester
New York, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The global genome editing market size is slated to expand at ~21.1% CAGR between 2024 and 2036. The market is poised to garner a revenue of USD 69.6...
Global Active Pharmaceutical Ingredient CDMO Market to Reach $156.3 Billion by 2030, Driven by Rising R&D Investments and Demand for Generic Drugs
November 10, 2023 08:03 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product (Highly Potent API, Antibody Drug Conjugate), By...
Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic Development in Gastrointestinal Diseases
November 10, 2023 01:35 ET
|
Sosei Group Corporation
Tokyo, Japan, Cambridge, UK and New York, USA – 10 November 2023 – Sosei Group Corporation (“Sosei Heptares”; TSE: 4565), the international biopharmaceutical company, and Kallyope, a clinical stage...
Stay Ahead of Regulatory Challenges in Pharmacovigilance with Expert Insights at Upcoming Training Course (January 22-25, 2024)
November 08, 2023 09:38 ET
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Pharmacovigilance QMS & Inspection Preparation Training Course" conference has been added to ResearchAndMarkets.com's offering. Since the...
Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma
November 06, 2023 10:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute announced the first patient has been treated in a novel Phase 0/1 clinical trial of...
Apnimed to Participate in Upcoming November Investor Conferences
November 06, 2023 08:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...
Seize Opportunities: Master Middle East Pharma Regulations Now (December 11-14, 2023)
November 03, 2023 09:18 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in the Middle East Training Course" conference has been added to ResearchAndMarkets.com's offering. This seminar...